1. Home
  2. SON vs LEGN Comparison

SON vs LEGN Comparison

Compare SON & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$50.68

Market Cap

4.9B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$27.93

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
LEGN
Founded
1899
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.9B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
SON
LEGN
Price
$50.68
$27.93
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$60.13
$61.33
AVG Volume (30 Days)
1.1M
3.1M
Earning Date
04-21-2026
05-12-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
N/A
EPS
0.68
N/A
Revenue
$7,518,753,000.00
N/A
Revenue This Year
$0.10
$42.68
Revenue Next Year
$1.82
$30.52
P/E Ratio
$74.32
N/A
Revenue Growth
41.72
N/A
52 Week Low
$38.65
$16.24
52 Week High
$58.44
$45.30

Technical Indicators

Market Signals
Indicator
SON
LEGN
Relative Strength Index (RSI) 54.65 43.10
Support Level $46.19 $23.10
Resistance Level $52.71 $28.70
Average True Range (ATR) 1.51 2.86
MACD 0.36 -0.55
Stochastic Oscillator 72.95 24.59

Price Performance

Historical Comparison
SON
LEGN

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: